Bookmark
Forward
PLEKHH2-ALK: A Novel In-frame Fusion With Durable Response to Alectinib: Utilizing RNA Sequencing in Search for Hidden Gene Fusions Susceptible to Targeted Therapy.
Misako Nagasaka, Amanda Fisher, Tahmida Chowdhury, Yubin Ge, Ammar Sukari
Clinical lung cancer 2021 Jan
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Misako Nagasaka, Amanda Fisher, Tahmida Chowdhury, Yubin Ge, Ammar Sukari.
PLEKHH2-ALK: A Novel In-frame Fusion With Durable Response to Alectinib: Utilizing RNA Sequencing in Search for Hidden Gene Fusions Susceptible to Targeted Therapy.
Clinical lung cancer.
2021 Jan;22(1):e51-e53
Mesh Tags
Adenocarcinoma of Lung
Anaplastic Lymphoma Kinase
Biomarkers, Tumor
Carbazoles
Cytoskeletal Proteins
Female
Humans
Lung Neoplasms
Middle Aged
Molecular Targeted Therapy
Oncogene Proteins, Fusion
Piperidines
Prognosis
Sequence Analysis, RNA
Substances
Biomarkers, Tumor
Carbazoles
Cytoskeletal Proteins
Oncogene Proteins, Fusion
Piperidines
plekhh2 protein, human
ALK protein, human
Anaplastic Lymphoma Kinase
alectinib
PMID: 32893122
View Full Text